About the Prolaris Test

The Prolaris® test provides an analysis of your individual tumor aggressiveness as well as a clinically validated prostate cancer-specific mortality risk. Two patients with the same PSA and Gleason scores may have a very different estimate of mortality risk when their Prolaris Score is included in their evaluation. Since cancer is the uncontrolled rapid growth of abnormal cells, an aggressive prostate tumor carries the potential risk of growing and spreading rapidly to other parts of your body.

 

The Prolaris Score is calculated by directly measuring the biology of the tumor and how fast the cells in your tumor or dividing. Since you have already had a biopsy which determined that you have prostate cancer, that tissue sample can also be used to determine your Prolaris Score. And, because every individual’s prostate cancer is different, the result of your Prolaris test is unique to you.

Patient Resources:

Below are several resources designed to help patients and their family better understand how the Prolaris test is used in a clinical setting, including a video as well as downloadable brochures. 

PCMs Brochure

This brochure, designed by pcmarkers.com, will help patients and their family further understand the test. 

Prolaris Brochure

This brochure, designed by Myraid, will help patients and their family further understand the test. 

Prolaris Sample Report

This sample report will help patients and their families understand how the results for this test are presented. 

Aurora, Colorado | Info@pcmarkers.com